These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 16515393)
41. Snipping away at human disease. Into the era of individually tailored therapies. Fischer J US News World Rep; 2000 Oct; 129(16):58-9. PubMed ID: 11184577 [No Abstract] [Full Text] [Related]
42. Pharmacogenetics and the practice of medicine. Roses AD Nature; 2000 Jun; 405(6788):857-65. PubMed ID: 10866212 [TBL] [Abstract][Full Text] [Related]
43. Drug discovery: past, present and future. Malik NN Drug Discov Today; 2008 Nov; 13(21-22):909-12. PubMed ID: 18852066 [No Abstract] [Full Text] [Related]
44. [The development of pharmacology and the appearance every year of newer and newer drugs has significantly complicated the work of the physician (editor)]. Ter Arkh; 1992; 64(8):3. PubMed ID: 1440390 [No Abstract] [Full Text] [Related]
45. [New drugs are tested on virtual patients. It will be possible to test new drugs on virtual patients, existing only in a computer]. Andreasen J Ugeskr Laeger; 2003 May; 165(19):1961-2. PubMed ID: 12795067 [No Abstract] [Full Text] [Related]
46. Old drugs, new bottles, therapeutic advantage? Somberg JC Am J Ther; 2002; 9(4):273-4. PubMed ID: 12115014 [No Abstract] [Full Text] [Related]
47. Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice. LLerena A; Peñas-Lledó EM Drug Metab Pers Ther; 2015 Sep; 30(3):143-5. PubMed ID: 26353178 [No Abstract] [Full Text] [Related]
48. Implications of pharmacogenomics for drug development and clinical practice. Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761 [TBL] [Abstract][Full Text] [Related]
49. Is primary care ready for pharmacogenetics? Voora D; Gage BF Pharmacogenomics; 2006 Jan; 7(1):1-3. PubMed ID: 16354118 [No Abstract] [Full Text] [Related]
50. Pharmacogenomics and reducing the frequency of adverse drug events. O'Kane DJ; Weinshilboum RM; Moyer TP Pharmacogenomics; 2003 Jan; 4(1):1-4. PubMed ID: 12517278 [No Abstract] [Full Text] [Related]
51. [Advances in pharmacology and progress in therapeutics]. Erill S Med Clin (Barc); 1983 Jul; 81(5):207-8. PubMed ID: 6621163 [No Abstract] [Full Text] [Related]
52. [The progress of pharmacology and the therapeutic revolution]. Penna M Rev Med Chil; 1988 Nov; 116(11):1201-6. PubMed ID: 3267905 [No Abstract] [Full Text] [Related]
53. [Pharmacology]. Zhou H; Su D; Zhu X Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(24):1724-6. PubMed ID: 12641945 [No Abstract] [Full Text] [Related]
54. [Where is pharmacology going in the 21st century?]. Lechat P Bull Mem Acad R Med Belg; 1988; 143(10-12):422-8. PubMed ID: 3267425 [No Abstract] [Full Text] [Related]
55. The impact of FDA guidance on pharmacogenomic data submissions on drug development. Little S IDrugs; 2005 Aug; 8(8):648-50. PubMed ID: 16044373 [TBL] [Abstract][Full Text] [Related]
56. [New developments in drug discovery]. Kharkevich DA Eksp Klin Farmakol; 2003; 66(3):74-9. PubMed ID: 12924242 [No Abstract] [Full Text] [Related]
57. The quest for a cure. Elion GB Annu Rev Pharmacol Toxicol; 1993; 33():1-23. PubMed ID: 8494337 [No Abstract] [Full Text] [Related]
58. New directions in diagnostics. Med Device Technol; 2000 Oct; 11(8):33. PubMed ID: 11185187 [TBL] [Abstract][Full Text] [Related]
60. What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects? Ozdemir V; Shear NH; Kalow W Drug Saf; 2001; 24(2):75-85. PubMed ID: 11235820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]